HRZ

HRZ is a venture capital firm established in 2022 and headquartered in Menlo Park, California. The firm focuses on supporting innovative Korean technology founders who are poised to leverage global market trends. HRZ invests in a diverse range of sectors, including consumer products, consumer services, information technology, advanced manufacturing, and other technology-driven industries. By backing these entrepreneurs, HRZ aims to foster growth and development in the Korean technology landscape while capitalizing on international opportunities.

Christopher Koh

Co-Founder and Managing Partner

9 past transactions

Twelve Labs

Series A in 2024
Twelve Labs specializes in a multimodal artificial intelligence platform designed to enhance video understanding across various applications. The platform enables businesses and developers to analyze video content by integrating visual and auditory data, facilitating the creation of intelligent video applications. It offers APIs for functions such as searching, generating, and classifying video content, allowing users to deploy solutions on any cloud, customize models, and fine-tune with their own data. Twelve Labs serves diverse industries, including technology, media, entertainment, and security, empowering clients to harness complex video information for a range of downstream tasks.

Nirvanana

Series A in 2024
Nirvanana is a game developer that develops an online gaming platform to connect gamers across the world.

Makestar

Series D in 2024
Makestar is a platform dedicated to K-culture content, connecting Hallyu stars with fans across the globe. It serves as a music crowdfunding platform that supports various projects related to Korean pop music, allowing artists and production companies to share their creative visions. By fostering interactions between fans and celebrities, Makestar enables fans to engage directly in the content creation process and facilitates the international advancement of K-pop artists. This unique model not only strengthens the bond between fans and artists but also enhances the global reach of Korean entertainment.

GCORE

Series A in 2024
GCORE is a social enterprise that focuses on providing training and support services for fieldworkers, enhancing their effectiveness in various environments. Through its digital platform, GCORE connects a global community of researchers, journalists, and aid workers, facilitating collaboration and ensuring that members have access to essential resources in one centralized location. Additionally, GCORE offers advanced web services that include CDN, hosting, storage, streaming, DNS, security, and cloud solutions. The company manages a global infrastructure designed to deliver edge and cloud-based services tailored to the needs of enterprise-level businesses. By combining these offerings, GCORE aims to maximize the impact of collaboration while supporting the safety and efficiency of its users in the field.

AITRICS

Series B in 2024
AITRICS is taking on the ultimate role of giving everyone access to the power of data-driven health intelligence by developing advanced clinical solutions that will revolutionize their lives. With a shared vision and a common purpose, passionate and dedicated professionals from diverse backgrounds came together to create the most exceptional team.

ImpriMed

Series A in 2023
ImpriMed, Inc. is a company that specializes in drug testing services, focusing on the responses of live cancer cells from pets, particularly those with lymphoma. Based in Palo Alto, California, with a branch office in Seoul, South Korea, ImpriMed uses individualized drug response prediction technology to assist veterinary oncologists in selecting appropriate anticancer treatments. By collecting genetic and cellular information from pet cancer cells, the company creates a patient-derived database that not only aids in veterinary oncology but also holds potential for applications in human cancer care. This data-driven approach enables veterinarians to make informed decisions on final treatment regimens, ultimately enhancing precision medicine in both animal and human oncology. ImpriMed was incorporated in 2017.

Haba24

Venture Round in 2022
Haba24 sells fun, educational, and original toys to develop the senses and learn scientific principles.

Dongnae

Series A in 2022
Dongnae is a real estate platform based in Seoul, established in 2020, that focuses on enhancing the renting experience in Korea. The company offers innovative products such as Dongnae FLEX and Dongnae PLUS, which provide renters with financial flexibility through low security deposits and adaptable lease terms. Their platform connects users with tailored information on available properties, facilitating a more efficient search for homes that meet individual preferences and requirements. By combining expertise in technology, finance, and real estate, Dongnae aims to transform perceptions of renting, empowering individuals to make informed choices about their living arrangements.

Contents First

Series B in 2022
Contents First, Inc. is a South Korean company that specializes in market research consulting and offers a range of services including press and public relations, social network marketing, and translation and localization. The company is best known for its online platform, Tappytoon, which serves as a digital-first comics and webnovel destination for over 8 million readers across more than 190 countries. Since its launch in 2016, Tappytoon has consistently ranked among the top comics apps by gross revenue on major app stores in numerous countries. The platform features a diverse library available in English, French, and German, showcasing exclusive, licensed content from prominent publishers in Korea and Asia. Tappytoon provides both premium and free digital comics and webnovels, including popular titles like "Solo Leveling" and "What's Wrong with Secretary Kim." Additionally, the platform collaborates with creators to produce original titles for various media formats, ensuring support for artists and storytellers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.